A detailed history of Nextech Invest Ag transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 12,067,246 shares of MRSN stock, worth $26.8 Million. This represents 3.72% of its overall portfolio holdings.

Number of Shares
12,067,246
Previous 9,526,146 26.68%
Holding current value
$26.8 Million
Previous $19.1 Million 19.12%
% of portfolio
3.72%
Previous 3.61%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.23 - $2.25 $3.13 Million - $5.72 Million
2,541,100 Added 26.68%
12,067,246 $22.8 Million
Q2 2024

Aug 14, 2024

BUY
$2.0 - $4.45 $11.3 Million - $25.2 Million
5,669,825 Added 147.03%
9,526,146 $19.1 Million
Q1 2024

May 15, 2024

SELL
$2.16 - $5.94 $4.58 Million - $12.6 Million
-2,122,006 Reduced 35.49%
3,856,321 $17.3 Million
Q4 2023

Feb 14, 2024

BUY
$1.11 - $2.34 $6.64 Million - $14 Million
5,978,327 New
5,978,327 $13.9 Million

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $216M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Nextech Invest Ag Portfolio

Follow Nextech Invest Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nextech Invest Ag, based on Form 13F filings with the SEC.

News

Stay updated on Nextech Invest Ag with notifications on news.